JP2022542540A5 - - Google Patents

Info

Publication number
JP2022542540A5
JP2022542540A5 JP2022501167A JP2022501167A JP2022542540A5 JP 2022542540 A5 JP2022542540 A5 JP 2022542540A5 JP 2022501167 A JP2022501167 A JP 2022501167A JP 2022501167 A JP2022501167 A JP 2022501167A JP 2022542540 A5 JP2022542540 A5 JP 2022542540A5
Authority
JP
Japan
Prior art keywords
frppo
independently
cancer
nhr
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022501167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542540A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/069630 external-priority patent/WO2021009068A1/en
Publication of JP2022542540A publication Critical patent/JP2022542540A/ja
Publication of JP2022542540A5 publication Critical patent/JP2022542540A5/ja
Pending legal-status Critical Current

Links

JP2022501167A 2019-07-12 2020-07-10 isoQC及び/又はQC酵素の阻害剤としてのN-置換-3,4-(縮合5-環)-5-フェニル-ピロリジン-2-オン化合物 Pending JP2022542540A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19185997.4 2019-07-12
EP19185997 2019-07-12
PCT/EP2020/069630 WO2021009068A1 (en) 2019-07-12 2020-07-10 N-substituted-3,4-(fused 5-ring)-5-phenyl-pyrrolidine-2-one compounds as inhibitors of isoqc and/or qc enzyme

Publications (2)

Publication Number Publication Date
JP2022542540A JP2022542540A (ja) 2022-10-05
JP2022542540A5 true JP2022542540A5 (cg-RX-API-DMAC7.html) 2023-07-18

Family

ID=67262155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022501167A Pending JP2022542540A (ja) 2019-07-12 2020-07-10 isoQC及び/又はQC酵素の阻害剤としてのN-置換-3,4-(縮合5-環)-5-フェニル-ピロリジン-2-オン化合物

Country Status (12)

Country Link
US (1) US20230077723A1 (cg-RX-API-DMAC7.html)
EP (1) EP3997091A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022542540A (cg-RX-API-DMAC7.html)
KR (1) KR20220054293A (cg-RX-API-DMAC7.html)
CN (1) CN114466849B (cg-RX-API-DMAC7.html)
AU (1) AU2020312647A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022000505A8 (cg-RX-API-DMAC7.html)
CA (1) CA3147154A1 (cg-RX-API-DMAC7.html)
IL (1) IL289784A (cg-RX-API-DMAC7.html)
MX (1) MX2022000521A (cg-RX-API-DMAC7.html)
PH (1) PH12022550079A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021009068A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4717089A3 (en) 2021-08-02 2026-06-24 Syngenta Crop Protection AG Microbiocidal pyrazole derivatives
AU2022203580A1 (en) * 2021-09-17 2023-04-06 Academia Sinica Methods of Increasing Cell Phagocytosis
EP4447682A1 (en) 2021-12-17 2024-10-23 Syngenta Crop Protection AG Microbiocidal pyrazole derivatives
TW202430514A (zh) 2022-09-30 2024-08-01 瑞士商先正達農作物保護股份公司 殺微生物之吡唑衍生物
PY2403614A (es) 2023-01-27 2025-09-11 Syngenta Crop Protection Ag Derivados de pirazol microbiocidas
PY2404467A (es) 2023-02-01 2025-03-31 Syngenta Crop Protection Ag Composiciones fungicidas
EP4455142A1 (en) 2023-04-26 2024-10-30 Scenic Immunology B.V. Novel inhibitor of qpctl and/or qc
PY2447478A (es) 2023-06-14 2025-03-18 Syngenta Crop Protection Ag Composiciones fungicidas
WO2025114167A1 (en) 2023-11-28 2025-06-05 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
AR134999A1 (es) 2024-02-02 2026-05-20 Syngenta Crop Protection Ag Derivados de pirazol microbiocidas
WO2025191053A1 (en) 2024-03-14 2025-09-18 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2025224308A1 (en) * 2024-04-25 2025-10-30 Scenic Immunology B.V. Qpctl inhibitors
WO2026022173A1 (en) 2024-07-26 2026-01-29 Syngenta Crop Protection Ag Microbiocidal pyrazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011002106A (es) * 2008-09-04 2011-04-07 Probiodrug Ag Inhibidores novedosos.
US8975417B2 (en) * 2013-05-27 2015-03-10 Novartis Ag Pyrazolopyrrolidine derivatives and their use in the treatment of disease
AU2014272695B2 (en) * 2013-05-28 2016-10-20 Novartis Ag Pyrazolo-pyrrolidin-4-one derivatives as BET inhibitors and their use in the treatment of disease
KR102084185B1 (ko) * 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
WO2019022600A1 (en) * 2017-07-24 2019-01-31 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis TREATMENT OF PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPA INTERACTION - CD47

Similar Documents

Publication Publication Date Title
AU2022200741B2 (en) Aminothiazole compounds as c-Kit inhibitors
EP3468960B1 (en) Chemical compounds as atf4 pathway inhibitors
JP7313354B2 (ja) Tlr阻害剤として有用なアミド置換されたインドール化合物
JP6517928B2 (ja) キナーゼ阻害剤として有用なインドールカルボキシアミド
KR20260061205A (ko) Kras 억제제 및 이의 용도
JP2023018094A (ja) アロステリックshp2阻害剤としてのピリジン化合物
JP2020525513A (ja) 癌および他の疾患を治療するためのatf4阻害剤としてのn−(3−(2−(4−クロロフェノキシ)アセトアミドビシクロ[1.1.1]ペンタン−1−イル)−2−シクロブタン−1−カルボキサミド誘導体および関連化合物
JP2020525512A (ja) 癌および他の疾患を処置するためのATF4阻害剤としての2−(4−クロロフェノキシ)−N−((1−(2−(4−クロロフェノキシ)エチンアゼチジン(ethynazetidin)−3−イル)メチル)アセトアミド誘導体および関連化合物
JP2021506889A (ja) Tlr阻害剤として有効な置換されたインドール化合物
BR112021000332A2 (pt) Compostos químicos
JP2019521109A (ja) 化学化合物
ES3018512T3 (es) Inhibidores de la integrina alfa v beta6
IL273983B2 (en) Concentrated imidazole derivatives substituted by tertiary hydroxy groups as p13k-gamma inhibitors
KR20170075756A (ko) 카르바졸 유도체
CN105849108A (zh) 磷脂酰肌醇3-激酶抑制剂的制备方法
JP2024545185A (ja) TLR7/8作動剤としてのピリド[4,3-d]ピリミジン系化合物
KR20170068596A (ko) 트리시클릭 회전장애이성질체 화합물
IL281634B1 (en) N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
AU2016334637A1 (en) 2-oxo-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
KR20250073137A (ko) Egfr 억제제 및 그의 용도
HK1246778A1 (zh) 一种新型的3-氮杂双环[3.1.0]己烷衍生物的盐的晶体以及其医药应用
EP4313956A1 (en) 8-cyclo-substituted quinazoline derivatives as lpa receptor 2 inhibitors
AU2024298553A1 (en) Salts and solid forms of compounds that modulate ikzf2